 |
Title:
The case of Bt GM maize MON 863
Description: For the first time in the world, an independent study lead by CSOs on the health risks of a GM maize authorized for consumption shows signs of hepatorenal toxicity (1). It is a countervaluation performed by CRIIGEN (France), of a regulatory study by the Monsanto Company, on rats fed with a GM maize (MON 863) over a three-month period.
Download:
|
|